Cell and gene therapies and complex biologics continue to push the boundaries of medicine; however, advancing these therapies from concept to commercialization requires specialized expertise at every stage of development. From cell line development and vector production to process optimization, scale-up, analytical characterization, and quality control, each step presents unique scientific and manufacturing challenges.
In this edition of the Outsourced Pharma Capabilities Update (OPCU), CDMOs highlight the capabilities that make biologics and advanced therapy programs possible, showcasing technologies, facilities, and technical expertise that help sponsors navigate complexity, maintain product quality, and prepare for clinical and commercial success. Watch the presentations below to review the partners and capabilities shaping the next generation of biologic and cell & gene therapies.
Recent Sessions Available On-Demand
Fill/Finish & Small Molecule – 4/21/2026 & 4/22/2026
Upcoming OPCU Topics & Times
Cell Therapy | 6/16/2026, AM Session
Cell Line Development | 6/16/2026, PM Session
Microbial Development & Manufacturing | 6/17/2026, AM Session
ADCs | 6/17/2026, PM Session
Access more on-demand OPCU recordings and upcoming sessions here.
